TherapeuticsMD (TXMD) Market Capitalization (2011 - 2026)

TherapeuticsMD (TXMD) has reported Market Capitalization for 16 consecutive years, with $25.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization rose 90.52% year-over-year to $25.6 million; the trailing twelve-month figure through Jun 2026 stood at $25.6 million (up 90.52% YoY), and the FY2025 full-year result was $18.9 million, up 90.23% from the prior year.
• Market Capitalization grew to $25.6 million in Q2 2026 per TXMD's latest filing, from $23.4 million in the prior quarter.
• Across five years, Market Capitalization topped out at $164.7 million in Q1 2022 and bottomed at $9.9 million in Q4 2024.
• Historically, Market Capitalization has averaged $38.0 million across 5 years, with a median of $25.8 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Market Capitalization sank 99.62% in 2022, then soared 118.38% in 2026.
• Over 5 years, Market Capitalization stood at $53.1 million in 2022, then sank by 51.13% to $25.9 million in 2023, then slumped by 61.78% to $9.9 million in 2024, then soared by 90.23% to $18.9 million in 2025, then surged by 35.58% to $25.6 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $25.6 million, $23.4 million, and $18.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.